THE FDA is warning women who
use the estrogen hormonal
replacement medication spray
EvaMist (estradiol), to avoid
unintentional exposure of children
and pets.
Sprayed on the arm, between the
wrist and elbow, the medication has
received eight post-marketing cases
of unintended exposure to EvaMist
in kids aged between 3-5yrs.
Adverse reactions to this exposure
include premature puberty, nipple
swelling and breast development in
females and breast enlargement in
males.
Pet side effects to EvaMist
exposure include mammary/nipple
enlargement and vulvar swelling.
For info see www.fda.gov.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jul 10
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.